Results 41 to 50 of about 29,753 (220)

Obstetric Thromboprophylaxis: The Swedish Guidelines

open access: yesAdvances in Hematology, 2011
Obstetric thromboprophylaxis is difficult. Since 10 years Swedish obstetricians have used a combined risk estimation model and recommendations concerning to whom, at what dose, when, and for how long thromboprophylaxis is to be administrated based on a ...
Pelle G. Lindqvist, Margareta Hellgren
doaj   +1 more source

Establishment of prophylactic enoxaparin dosing recommendations to achieve targeted anti-factor Xa concentrations in children with CHD [PDF]

open access: yes, 2018
Background Enoxaparin may be used to prevent central venous catheter-related thrombosis in patients with CHD. We aimed to determine whether current enoxaparin dosing regimens effectively achieve anti-factor Xa concentrations within prophylactic goal ...
Israel, Emily N.   +2 more
core   +1 more source

The Use of venous thromboembolism prophylaxis in relatioN to patiEnt risk profilINg (TUNE IN) Wave 3 study

open access: yesSouth African Medical Journal
Background. Thromboprophylaxis significantly reduces the risk of venous thromboembolism (VTE) in hospitalised medical and surgical patients. Nonetheless, the implementation of thromboprophylaxis in South Africa (SA) and worldwide is low.
J Bassett, E Schapkaitz, B Jacobson
doaj   +1 more source

Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study

open access: yesBMJ Medicine
Objective To determine the balance of costs, risks, and benefits for different thromboprophylaxis strategies for medical patients during hospital admission.Design Decision analysis modelling study.Setting NHS hospitals in England.Population Eligible ...
Daniel Horner   +7 more
doaj   +1 more source

Underutilization of pharmacological thromboprophylaxis in obstetrics and gynaecology patients in the absence of a risk assessment tool

open access: yesJournal of Taibah University Medical Sciences, 2018
Objective: This study was conducted to determine the risk factors for developing venous thromboembolism and to evaluate adherence to thromboprophylaxis guidelines among patients hospitalized in Obstetrics and Gynaecology units.
Galila F. Zaher, FRCPath
doaj   +1 more source

How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?

open access: yesClinical and Applied Thrombosis/Hemostasis, 2022
Low-molecular-weight heparin (LMWH) is suggested for thromboprophylaxis in pregnant women with previous venous thromboembolism (VTE ) . Anyway, there is only limited amount of studies evaluating the effect of LMWH on hemostatic parameters during ...
Lucia Stanciakova MD, PhD   +12 more
doaj   +1 more source

Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience. [PDF]

open access: yes, 2014
Plasma exchange (PEX) is a life-saving therapeutic procedure in patients with thrombotic thrombocytopaenic purpura (TTP) and other thrombotic microangiopathic anaemias (TMAs). However, it may be associated with significant complications, exacerbating the
Collier, D   +5 more
core   +2 more sources

Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation

open access: yesHealth Technology Assessment, 2019
Background: Thromboprophylaxis can reduce the risk of venous thromboembolism (VTE) during lower-limb immobilisation, but it is unclear whether or not this translates into meaningful health benefit, justifies the risk of bleeding or is cost-effective ...
Abdullah Pandor   +9 more
doaj   +1 more source

Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines

open access: yesSwiss Medical Weekly, 2020
AIMS OF THE STUDY Many centres have noticed a high number of venous thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia.
Pierre Fontana   +5 more
doaj   +1 more source

Thromboprophylaxis in people hospitalized with COVID‐19: Assessing intermediate or standard doses in a retrospective cohort study

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Background and Objectives Current clinical guidelines recommend thromboprophylaxis for adults hospitalized with coronavirus disease 2019 (COVID‐19), yet it is unknown whether higher doses of thromboprophylaxis offer benefits beyond standard doses ...
Kathleen M. Andersen   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy